Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03678766
Other study ID # 181015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2018
Est. completion date April 30, 2023

Study information

Verified date May 2023
Source University of California, San Diego
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or clinical Binge Eating Disorder (BED) with comorbid overweight/obesity (OW/OB).


Description:

The investigators have developed a new model for the treatment of obesity, called Regulation of Cues (ROC), which is based on Schachter's Externality Theory. This study will compare ROC with Cognitive Behavior Therapy for individuals with Binge Eating Disorder. The investigators will recruit and randomize 120 male and female Veterans with BED and subclinical BED with comorbid overweight/obesity, provide 5 months of treatment and follow participants for 6-months post-treatment. Participants will complete assessments at baseline, mid-treatment (week 9), post-treatment (week 20), and 6-month follow-up (week 44). This study will be the first to contribute to a body of literature developing treatments for BED and overweight/obesity in the Veterans Affairs (VA) and/or military health care systems.


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date April 30, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. All participants will be Veterans between the ages of 18-65 meeting criteria for overweight, with a 45= BMI =25. 2. Participants will meet Diagnostic and Statistical Manual-5 (DSM-5) criteria for BED or subclinical BED 3. Participants will be willing and able to participate in assessment visits and treatment sessions at University of California, San Diego (UCSD). 4. Participants will be able to provide data in English through interviews and questionnaires and understand treatment materials in English. 5. Participants will be willing to maintain contact with the investigators for 11 months. 6. Participants will be free of serious or unstable medical (current symptoms of angina, stroke, heart disease or other serious medical condition that would make physical activity unsafe or impossible at a moderate level) or psychiatric illness (i.e., active suicidal ideation, history of suicide attempt within 1 year, current unmanaged psychosis, manic episode, anorexia nervosa, bulimia nervosa, or substance abuse within the past year) or psychosocial instability (e.g., homelessness) that could compromise study participation. 7. Participants will be free from conditions in which exercise or weight loss will be detrimental to the participant's health (e.g., pregnancy); pharmacotherapy for obesity or binge eating disorder (e.g., Orlistat or Meridia) or bariatric surgery within the past 6 months or planning to start such treatments in the next 11 months. 8. Participants will not be moving out of the San Diego area for the duration of their study enrollment (11 months). 9. Participants will not be pregnant, planning to get pregnant in the 11-month study period or lactating. 10. Participants will not be participating in group or individual psychotherapy for binge eating or weight management. 11. Participants with medical or psychological problems or taking medications that could make adherence with the study protocol difficult or dangerous will not be included.

Study Design


Intervention

Behavioral:
Regulation of Cues (ROC)
Participants are provided information about basic learning theory and how physiological responses to food cues develop and can be managed. Lack of sensitivity to appetite and satiety cues and increased sensitivity to food cues will be discussed. Coping skills are presented to assist in mastery and toleration of food cue sensitivity. Participants will complete experiential learning exercises with food, and taught to monitor their hunger, satiety, and cravings. The physical activity program will focus on increasing both lifestyle activity and structured exercise programs.
Cognitive Behavior Therapy (CBT)
Participants are taught to identify problems in eating, thinking, and mood patterns that served to trigger binge episodes through self-monitoring and to gradually develop alternative patterns aimed at facilitating healthy, binge-free eating patterns. Participants are taught to eat a healthy variety of foods and reducing the avoidance of "forbidden" foods that are typically consumed during a binge.

Locations

Country Name City State
United States UCSD Center for Healthy Eating and Activity Research (CHEAR) La Jolla California

Sponsors (3)

Lead Sponsor Collaborator
University of California, San Diego San Diego Veterans Healthcare System, United States Department of Defense

Country where clinical trial is conducted

United States, 

References & Publications (2)

Boutelle KN, Zucker N, Peterson CB, Rydell S, Carlson J, Harnack LJ. An intervention based on Schachter's externality theory for overweight children: the regulation of cues pilot. J Pediatr Psychol. 2014 May;39(4):405-17. doi: 10.1093/jpepsy/jst142. Epub 2014 Jan 23. — View Citation

Boutelle KN, Zucker NL, Peterson CB, Rydell SA, Cafri G, Harnack L. Two novel treatments to reduce overeating in overweight children: a randomized controlled trial. J Consult Clin Psychol. 2011 Dec;79(6):759-71. doi: 10.1037/a0025713. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Attendance The number of treatment visits attended Post-Treatment (5 months following baseline)
Primary Acceptability Average likert ratings to questions, such as "How much did you enjoy the treatment?" and "How helpful did you find the treatment?" Post-Treatment (5 months following baseline)
Primary Binge Eating as measured by the Eating Disorder Examination (EDE) Diagnosis of Binge Eating Disorder (BED) and subclinical BED, number of OBEs (large amount of food and loss of control), objective overeating episodes (large amount of food without loss of control), and SBEs (lack of large amount of food with loss of control) determined by responses to the EDE. Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Primary Binge Eating as measured by the Binge Eating Scale (BES) Dimensional score of binge eating consisting of items to describe binge eating behaviors and feelings and cognitions associated with binge eating. Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Primary Binge Eating as measured by the Eating Disorder Examination-Questionnaire (EDE-Q) Three question items from the questionnaire to calculate the number of binge eating episodes and number of days participants experienced a binge eating episode. Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Primary Body Mass Index (BMI) as measured by weight and height Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Primary Energy intake Calorie intake estimated by 24-hour dietary recalls on 3 non-consecutive days Changes from baseline at an average of 20 weeks and 44 weeks
Secondary Satiety Responsiveness Self-reported satiety responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ) Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Secondary Food Responsiveness Self-reported food responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ) Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
Secondary Reward-Based Eating Scales to evaluate reward-related eating measured by the Reward-Based Eating Drive Scale (RED-13) Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2